Barclays
AMED

Barclays’s Amedisys AMED Stock Holding History

Barclays’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$473K – 4850
2020
Q3 		$473K Hold
2,000
– – ﹤0.01% 3265
2020
Q2 		$397K Sell
2,000
-7,400
-79% -$1.38M ﹤0.01% 3535
2020
Q1 		$1.73M Buy
9,400
+8,300
+755% +$1.48M ﹤0.01% 2419
2019
Q4 		$184K Buy
1,100
+1,000
+1,000% +$149K ﹤0.01% 5099
2019
Q3 		$13K Sell
100
-500
-83% -$65.1K ﹤0.01% 6301
2019
Q2 		$73K Sell
600
-7,100
-92% -$843K ﹤0.01% 5898
2019
Q1 		$949K Buy
7,700
+4,000
+108% +$502K ﹤0.01% 3452
2018
Q4 		$433K Buy
3,700
+3,500
+1,750% +$413K ﹤0.01% 3931
2018
Q3 		$25K Buy
+200
New +$22.1K ﹤0.01% 6391
2018
Q2 		– Sell
-600
Closed -$36K – 6938
2018
Q1 		$36K Buy
600
+500
+500% +$28.5K ﹤0.01% 6124
2017
Q4 		$5K Sell
100
-5,300
-98% -$279K ﹤0.01% 6657
2017
Q3 		$302K Sell
5,400
-1,900
-26% -$100K ﹤0.01% 4064
2017
Q2 		$459K Buy
+7,300
New +$425K ﹤0.01% 3612
2017
Q1 		– Sell
-500
Closed -$21K – 6729
2016
Q4 		$21K Buy
+500
New +$21.3K ﹤0.01% 5593
2016
Q3 		– Sell
-200
Closed -$10K – 6581
2016
Q2 		$10K Sell
200
-200
-50% -$10.1K ﹤0.01% 5525
2016
Q1 		$19K Sell
400
-1,600
-80% -$61.7K ﹤0.01% 5234
2015
Q4 		$78K Hold
2,000
– – ﹤0.01% 4556
2015
Q3 		$74K Sell
2,000
-3,100
-61% -$131K ﹤0.01% 4793
2015
Q2 		$199K Buy
5,100
+2,900
+132% +$90.4K ﹤0.01% 4146
2015
Q1 		$57K Sell
2,200
-2,500
-53% -$70.5K ﹤0.01% 5189
2014
Q4 		$136K Sell
4,700
-300
-6% -$7.41K ﹤0.01% 4942
2014
Q3 		$100K Sell
5,000
-2,900
-37% -$56K ﹤0.01% 5325
2014
Q2 		$126K Buy
7,900
+4,100
+108% +$58.1K ﹤0.01% 5238
2014
Q1 		$53K Buy
3,800
+900
+31% +$13.9K ﹤0.01% 5943
2013
Q4 		$41K Sell
2,900
-14,700
-84% -$237K ﹤0.01% 6314
2013
Q3 		$299K Buy
17,600
+13,400
+319% +$199K ﹤0.01% 4640
2013
Q2 		$49K Buy
+4,200
New +$48.1K ﹤0.01% 6314

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's AMED Position: Q3 2025 in Review

Barclays sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,221 shares — an estimated $1.4M sold.

Barclays first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $11.9M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Barclays reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 14,221 Amedisys shares in Q3 2025, an estimated $1.4M.
  • Barclays first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Barclays's Amedisys position peaked at $11.9M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.